Literature DB >> 1422397

Risk of prostate, ovarian, and endometrial cancer among relatives of women with breast cancer.

H Tulinius1, V Egilsson, G H Olafsdóttir, H Sigvaldason.   

Abstract

OBJECTIVE: To investigate the risk of prostate, ovarian, and endometrial cancer among relatives of patients with breast cancer.
DESIGN: Cohort study of 947 pedigrees in which the proband had breast cancer, linked with the Icelandic cancer registry.
SETTING: Iceland.
SUBJECTS: The 947 pedigrees included 29,725 people, of whom 1539 had breast cancer, 467 had prostate cancer, 135 ovarian cancer, and 105 endometrial cancer. MAIN OUTCOME MEASURES: Risk of prostate, ovarian, and endometrial cancer among blood relatives of women with breast cancer compared with risk in spouses.
RESULTS: The risk of prostate cancer was significantly raised for all relatives (1.5), first degree relatives (1.4), and second degree relatives (1.3) of women with breast cancer. Risk of ovarian cancer was raised for all relatives (1.9) and first degree relatives (1.9) and risk of endometrial cancer was raised for all relatives only (1.9). The risk of prostate cancer was raised if the proband with breast cancer had a first degree relative with prostate cancer.
CONCLUSIONS: Coaggregation exists between breast cancer and cancers of the prostate, ovaries, and endometrium. This risk relation is probably based on genes which act by increasing the risk for cancer at these sites. Environmental factors that are common among relatives may also play a part. Continued research is required into pathophysiological mechanisms that could explain these observations.

Entities:  

Mesh:

Year:  1992        PMID: 1422397      PMCID: PMC1883041          DOI: 10.1136/bmj.305.6858.855

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


  10 in total

1.  Body mass index and risk of breast cancer. A prospective study of 23,826 Norwegian women.

Authors:  L J Vatten; S Kvinnsland
Journal:  Int J Cancer       Date:  1990-03-15       Impact factor: 7.396

2.  Concerning a familial association between breast cancer and both prostatic and uterine malignancies.

Authors:  E U Thiessen
Journal:  Cancer       Date:  1974-10       Impact factor: 6.860

3.  Familial breast-ovarian cancer locus on chromosome 17q12-q23.

Authors:  S A Narod; J Feunteun; H T Lynch; P Watson; T Conway; J Lynch; G M Lenoir
Journal:  Lancet       Date:  1991-07-13       Impact factor: 79.321

4.  Genetic epidemiology of breast cancer: segregation analysis of 200 Danish pedigrees.

Authors:  W R Williams; D E Anderson
Journal:  Genet Epidemiol       Date:  1984       Impact factor: 2.135

5.  Familial association of breast/ovarian carcinoma.

Authors:  H T Lynch; R E Harris; H A Guirgis; K Maloney; L L Carmody; J F Lynch
Journal:  Cancer       Date:  1978-04       Impact factor: 6.860

6.  Epidemiology of breast cancer in families in Iceland.

Authors:  H Tulinius; H Sigvaldason; G Olafsdóttir; L Tryggvadóttir
Journal:  J Med Genet       Date:  1992-03       Impact factor: 6.318

7.  A genetic linkage study of familial breast-ovarian cancer.

Authors:  R E Ferrell; D E Anderson; A Chidambaram; T R Marino; M Badzioch
Journal:  Cancer Genet Cytogenet       Date:  1989-04

8.  Allele increasing susceptibility to human breast cancer may be linked to the glutamate-pyruvate transaminase locus.

Authors:  M C King; R C Go; R C Elston; H T Lynch; N L Petrakis
Journal:  Science       Date:  1980-04-25       Impact factor: 47.728

9.  Evaluating genetic association among ovarian, breast, and endometrial cancer: evidence for a breast/ovarian cancer relationship.

Authors:  J M Schildkraut; N Risch; W D Thompson
Journal:  Am J Hum Genet       Date:  1989-10       Impact factor: 11.025

10.  Surveillance and management of patients at high genetic risk for ovarian carcinoma.

Authors:  H T Lynch; W A Albano; J F Lynch; P M Lynch; A Campbell
Journal:  Obstet Gynecol       Date:  1982-05       Impact factor: 7.661

  10 in total
  32 in total

1.  Germ-line BRCA1 mutations in selected men with prostate cancer.

Authors:  A A Langston; J L Stanford; K G Wicklund; J D Thompson; R G Blazej; E A Ostrander
Journal:  Am J Hum Genet       Date:  1996-04       Impact factor: 11.025

2.  Prostate cancer risk in men with prostate and breast cancer family history: results from the REDUCE study (R1).

Authors:  J-A Thomas; L Gerber; D M Moreira; R J Hamilton; L L Bañez; R Castro-Santamaria; G L Andriole; W B Isaacs; J Xu; S J Freedland
Journal:  J Intern Med       Date:  2012-01-16       Impact factor: 8.989

Review 3.  BRCA2 and pancreatic cancer.

Authors:  Ali Naderi; Fergus J Couch
Journal:  Int J Gastrointest Cancer       Date:  2002

4.  Frequent occurrence of BRCA2 linkage in Icelandic breast cancer families and segregation of a common BRCA2 haplotype.

Authors:  J Gudmundsson; G Johannesdottir; A Arason; J T Bergthorsson; S Ingvarsson; V Egilsson; R B Barkardottir
Journal:  Am J Hum Genet       Date:  1996-04       Impact factor: 11.025

5.  The role of germline mutations in the BRCA1/2 and mismatch repair genes in men ascertained for early-onset and/or familial prostate cancer.

Authors:  Sofia Maia; Marta Cardoso; Paula Paulo; Manuela Pinheiro; Pedro Pinto; Catarina Santos; Carla Pinto; Ana Peixoto; Rui Henrique; Manuel R Teixeira
Journal:  Fam Cancer       Date:  2016-01       Impact factor: 2.375

6.  Brca2 and Trp53 deficiency cooperate in the progression of mouse prostate tumourigenesis.

Authors:  Jeffrey C Francis; Afshan McCarthy; Martin K Thomsen; Alan Ashworth; Amanda Swain
Journal:  PLoS Genet       Date:  2010-06-24       Impact factor: 5.917

7.  Prostate cancer in BRCA2 germline mutation carriers is associated with poorer prognosis.

Authors:  S M Edwards; D G R Evans; Q Hope; A R Norman; Y Barbachano; S Bullock; Z Kote-Jarai; J Meitz; A Falconer; P Osin; C Fisher; M Guy; S G Jhavar; A L Hall; L T O'Brien; B N Gehr-Swain; R A Wilkinson; M S Forrest; D P Dearnaley; A T Ardern-Jones; E C Page; D F Easton; R A Eeles
Journal:  Br J Cancer       Date:  2010-08-24       Impact factor: 7.640

8.  Familial effects of prostate and other cancers on lifetime breast cancer risk.

Authors:  D E Anderson; M D Badzioch
Journal:  Breast Cancer Res Treat       Date:  1993-11       Impact factor: 4.872

9.  Linkage analysis of chromosome 17q markers and breast-ovarian cancer in Icelandic families, and possible relationship to prostatic cancer.

Authors:  A Arason; R B Barkardóttir; V Egilsson
Journal:  Am J Hum Genet       Date:  1993-04       Impact factor: 11.025

Review 10.  The role of the BRCA2 gene in susceptibility to prostate cancer revisited.

Authors:  Elaine A Ostrander; Miriam S Udler
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2008-08       Impact factor: 4.254

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.